MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$34,355K
Deferred income tax
$9,277K
Amortization and
depreciation
$4,816K
Deferred revenue
$1,081K
Prepaid expenses and
other current assets
-$950K
Other, net
-$581K
Cash flows from
operating activities
$32,560K
Canceled cashflow
$18,500K
Net decrease in
cash, cash...
-$39,205K
Canceled cashflow
$32,560K
Proceeds from issuance of
common shares for...
$713K
Proceeds from the sale and
maturities of investments
$109,000K
Accounts receivable, net
$7,721K
Accrued expenses and
other liabilities
-$5,592K
Net amortization of
premiums and discounts on...
$2,319K
Share-based compensation
-$866K
Inventory
$720K
Accounts payable
-$652K
Foreign exchange (gain)
loss on revaluation...
$416K
Operating lease
liabilities
-$214K
Cash flows from
financing activities
-$53,685K
Canceled cashflow
$713K
Cash flows from
investing activities
-$18,080K
Canceled cashflow
$109,000K
Purchase of common shares
under share...
$36,165K
Tax withholding
payments related to net...
$14,580K
Payments of principal
portion of monoplant...
$3,653K
Purchases of investments
$127,041K
Purchases of property,
equipment and intangible...
$39K
Back
Back
Cash Flow
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)
source: myfinsight.com